Fremont, CA, United States of America

Target Therapeutics, Inc.


USPTO Granted Patents = 211

% Expired Patents = 1.9


Trademarks = 2

Forward Citations = 44,051

Loading Chart...
Loading Chart...

103 inventors (with patents filed for the assignee):

goldMedal Erik T Engelson (50 out of 60 patents)

silverMedal Gene L Samson (48 out of 63 patents)

bronzeMedal Ivan Sepetka (28 out of 112 patents)

4.  Son M Gia (21 out of 44 patents)

5.  Thomas J Palermo (18 out of 54 patents)

6.  Joseph Charles Eder (16 out of 52 patents)

7.  Uriel Hiram Chee (15 out of 18 patents)

8.  Michael J Mariant (15 out of 15 patents)

9.  Michael P Wallace (14 out of 149 patents)

10.  Kim D Nguyen (12 out of 38 patents)

11.  Hong Doan (12 out of 18 patents)

12.  U Hiram Chee (12 out of 24 patents)

13.  David J Kupiecki (11 out of 29 patents)

14.  Nga Thi Van (11 out of 11 patents)

15.  Christopher G Ken (10 out of 13 patents)


Core Competencies:
Catheter
Vaso-Occlusive Coil
Mechanical Clot Treatment
Guidewire
Endovascular
Detachable Implant
Balloon Catheter
Bioactive Coating
Electrolytic Detachment
Aneurysm Closure
Braided Catheter
Flexible Coil

211 patents:

Target Therapeutics, Inc., based in Fremont, CA, specializes in the development of innovative vaso-occlusive devices aimed at treating various vascular conditions. The company focuses on advanced technologies such as catheters, vaso-occlusive coils, and mechanical clot treatment solutions. Their expertise extends to endovascular procedures, incorporating detachable implants and balloon catheters, as well as bioactive coatings to enhance device performance. Target Therapeutics is committed to improving patient outcomes through cutting-edge medical device solutions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

211 Patents

#11 in Fremont, CA

#429 in California

#1,971 in US

#4,032 in the World

Fremont, CA (US)
Fremont, CA, United States of America
Forward Citations = 44,051

103 inventors:

Please report any incorrect information to [email protected]
Loading…